K. Zahaf

发表

[Accreditation of the activity of molecular pathology according to ISO 15189: key steps to follow and the main potential pitfalls].

J. Sabourin, E. Selva, P. Hofman, 2013, Annales de pathologie.

Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.

P. Bahadoran, R. Ballotti, G. Poissonnet, 2015, Journal of the American Academy of Dermatology.

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes

G. Poissonnet, P. Hofman, C. Bonnetaud, 2022, Diagnostics.

Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma

C. Marquette, P. Brest, P. Hofman, 2016 .

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients

A. Stenzinger, C. Marquette, J. Benzaquen, 2019, Cancers.

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies.

C. Marquette, J. Sabourin, P. Hofman, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2

P. Bahadoran, C. Bertolotto, R. Ballotti, 2016, Oncogene.

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

C. Marquette, P. Hofman, V. Hofman, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.

C. Marquette, J. Benzaquen, P. Hofman, 2022, Lung cancer.

Association of combined PD‐L1 expression and tumour‐infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma

P. Hofman, V. Hofman, J. Lacour, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

C. Marquette, J. Benzaquen, P. Hofman, 2020, Cancers.

PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome

C. Marquette, E. Brambilla, P. Hofman, 2016, Modern Pathology.

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

C. Marquette, P. Hofman, V. Hofman, 2012 .

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System

C. Marquette, J. Benzaquen, P. Hofman, 2021, Frontiers in Pharmacology.

Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples.

C. Marquette, J. Benzaquen, P. Hofman, 2023, Lung cancer.

Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.

C. Marquette, S. Leroy, J. Mazières, 2018, Lung cancer.

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank

C. Bertolotto, P. Hofman, B. Mograbi, 2023, Cancers.

[Setting up a department of molecular pathology in oncology in a pathology laboratory (LPCE, CHU de Nice)].

C. Marquette, L. Castillo, J. Santini, 2013, Annales de pathologie.

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice

C. Bertolotto, B. Mograbi, C. Bonnetaud, 2023, International journal of molecular sciences.

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.

C. Marquette, J. Mazières, J. Sabourin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.

S. Baillif, O. Bordone, K. Zahaf, 2023, Pathology.

Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non-Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging.

R. Schiappa, C. Bonnetaud, E. Long-Mira, 2024, The American journal of surgical pathology.